Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on h 1 antihistamines: A randomized, placebo-controlled study;Erratum: Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: A randomized, placebo-controlled study (Journal of Investigative Dermatology (2015) 135 (67-75)) DOI: 10.1038/jid.2014.306)

Journal of Investigative Dermatology

Volumn 135, Issue 3, 2015, Pages 925-

  Saini, Sarbjit S ^a   Bindslev Jensen, Carsten ^a   Maurer, Marcus ^a   Grob, Jean Jacques ^a   Bülbül Baskan, Emel ^a   Bradley, Mary S ^a   Canvin, Janice ^a   Rahmaoui, Abdelkader ^a   Georgiou, Panayiotis ^a   Alpan, Oral ^a   Spector, Sheldon ^a   Rosén, Karin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 84922628447     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.306     Document Type: Article

References (0)